Takeda Pharmaceutical Co Ltd Insider Trading
Every director, officer and 10% holder of Takeda Pharmaceutical Co Ltd has to report each trade in its stock within two business days of making it. This is those filings.
TAK on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Lauren Rusckowski DupreyChief Transformation Officer2026-09-1434.5K shat $18.54 | Sale | $640.3K |
| Andrew Stewart PlumpPresident, R&D2026-09-02116.2K shat $18.49 | Sale10b5-1 plan | $2.1M |
| Andrew Stewart PlumpPresident, R&D2026-08-1919.7K shat $18.49 | Sale10b5-1 plan | $363.3K |
| Nicola Deidre Petal GreenwayChief Human Resources Officer2026-08-1813K shat $18.11 | Sale | $235.1K |
| Elaine Mary ShannonPres., Global Supply & Quality2026-08-1120.4K shat $17.55 | Sale | $357.4K |
| Awny Samaan Botros FarajallahChief Medical Officer2026-08-1014K shat $17.10 | Sale | $239.5K |
| Ramy Riad Ahmed IbrahimPresident, PDT BU2026-08-107.3K shat $17.10 | Sale | $124.4K |
| Rhonda Janice PachecoPresident, U.S. Business Unit2026-08-1016.9K shat $17.10 | Sale | $289K |
| Lauren Rusckowski DupreyChief Transformation Officer2026-08-1047.6K shat $17.10 | Sale | $813.7K |
| Andrew Stewart PlumpPresident, R&D2026-08-10165.4K shat $17.10 | Sale | $2.8M |
| Agosti Marcello PignagnoliHead, Strat. & Port. Dev2026-08-1023K shat $17.10 | Sale | $392.6K |
| Teresa Marie BitettiPresident, OBU2026-08-1050K shat $17.10 | Sale | $855.2K |
| Elaine Mary ShannonPres., Global Supply & Quality2026-08-104K shat $17.10 | Sale | $68K |
| Gabriele RicciChief Data & Tech. Officer2026-08-1025.1K shat $17.10 | Sale | $429K |
| Nicola Deidre Petal GreenwayChief Human Resources Officer2026-08-106.8K shat $17.10 | Sale | $115.8K |
| Julie So-Young KimPresident and CEO2026-08-1089.1K shat $17.10 | Sale | $1.5M |
| Giles Richard PlatfordPresident, IBU2026-08-1031.1K shat $17.10 | Sale | $531.5K |
| Natalie Anne Marie FurneyGlobal General Counsel2026-08-1030.9K shat $17.10 | Sale | $527.8K |
| Nicola Deidre Petal GreenwayChief Human Resources Officer2026-08-10975 shat $17.50 | Sale | $17.1K |
| Nicola Deidre Petal GreenwayChief Human Resources Officer2026-08-1033.6K shat $17.51 | Sale | $588.7K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on TAK
Follow Takeda Pharmaceutical Co Ltd (TAK) by email
New trades in Takeda Pharmaceutical Co Ltd (TAK) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.